
Stereotaxis STXS
$ 1.85
7.56%
Quarterly report 2026-Q1
added 05-13-2026
Stereotaxis ROCE Ratio 2011-2026 | STXS
Annual ROCE Ratio Stereotaxis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -164.02 | -406.89 | -133.63 | -71.27 | -38.08 | -16.03 | -15.36 | -29.53 | 30.42 | 43.76 | -175.19 | -74.48 | -121.59 | 713.97 | 3546.83 | -180.99 | -311.96 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3546.83 | -406.89 | 152.7 |
Quarterly ROCE Ratio Stereotaxis
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -625.31 | -642.33 | -590.7 | -350.14 | -174.4 | -140.41 | -111.09 | -96.7 | -83.86 | -71.84 | -48.14 | -61.5 | -52.61 | -39.71 | -27.06 | -31.57 | -23.76 | -20.39 | -15.99 | -16.17 | -18.07 | -21.92 | -15.99 | -24.67 | -72.24 | -152.05 | -142.65 | -143.28 | -132.97 | -78.06 | 8.17 | 13.63 | 21.89 | 27.17 | 20.01 | 25.16 | 29.47 | 29.86 | 22.94 | 32.34 | 45.44 | 53.43 | 45.4 | 54.54 | 60.13 | 72.59 | 54.83 | 59.8 | 75.34 | 82.57 | 51.87 | 99.96 | 145.68 | 167.55 | 145.33 | 48.1 | 50.69 | 46.54 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 167.55 | -642.33 | -41.98 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
8.29 | $ 61.75 | 0.49 % | $ 12.3 B | ||
|
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | ||
|
ICU Medical
ICUI
|
2.02 | $ 129.31 | 4.57 % | $ 3.19 B | ||
|
Alcon
ALC
|
-2.56 | $ 67.28 | 1.48 % | $ 40.4 B | ||
|
Intuitive Surgical
ISRG
|
16.53 | $ 449.03 | 1.69 % | $ 160 B | ||
|
iRhythm Technologies
IRTC
|
-37.58 | $ 117.0 | 2.78 % | $ 3.74 B | ||
|
Repro Med Systems
KRMD
|
-17.44 | $ 4.0 | 1.01 % | $ 185 M | ||
|
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | ||
|
LeMaitre Vascular
LMAT
|
17.26 | $ 101.43 | 0.1 % | $ 2.3 B | ||
|
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | ||
|
Masimo Corporation
MASI
|
-25.35 | $ 178.79 | -0.01 % | $ 9.53 B | ||
|
Milestone Scientific
MLSS
|
-202.54 | $ 0.4 | 14.99 % | $ 32.8 M | ||
|
Ekso Bionics Holdings
EKSO
|
-147.62 | - | - | $ 28.6 M | ||
|
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
769.63 | $ 6.13 | 3.81 % | $ 52 K | ||
|
Envista Holdings Corporation
NVST
|
6.96 | $ 23.77 | 3.15 % | $ 3.99 B | ||
|
Haemonetics Corporation
HAE
|
27.02 | $ 59.56 | 4.79 % | $ 3 B | ||
|
STERIS plc
STE
|
13.12 | $ 215.97 | 0.67 % | $ 21.3 B | ||
|
Isoray
ISR
|
-54.85 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
-27.87 | $ 143.82 | 2.71 % | $ 6.97 B | ||
|
STAAR Surgical Company
STAA
|
-26.65 | $ 33.05 | 1.38 % | $ 1.64 B | ||
|
InfuSystem Holdings
INFU
|
20.79 | $ 10.16 | 5.07 % | $ 210 M | ||
|
Microbot Medical
MBOT
|
-19.01 | $ 1.74 | 0.58 % | $ 79.7 M | ||
|
Teleflex Incorporated
TFX
|
0.44 | $ 135.18 | 1.81 % | $ 6.03 B | ||
|
Utah Medical Products
UTMD
|
9.56 | $ 64.17 | 0.27 % | $ 208 M | ||
|
Merit Medical Systems
MMSI
|
11.66 | $ 64.49 | 1.13 % | $ 3.82 B | ||
|
West Pharmaceutical Services
WST
|
18.42 | $ 305.5 | 0.55 % | $ 22.1 B | ||
|
DENTSPLY SIRONA
XRAY
|
-31.52 | $ 9.84 | 1.03 % | $ 1.96 B | ||
|
Pulse Biosciences
PLSE
|
-95.39 | $ 26.09 | 4.57 % | $ 1.76 B | ||
|
Retractable Technologies
RVP
|
-28.47 | $ 0.66 | -2.35 % | $ 19.8 M | ||
|
Pro-Dex
PDEX
|
22.96 | $ 63.47 | 4.43 % | $ 209 M | ||
|
Predictive Oncology
POAI
|
-379.14 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
-4.46 | $ 24.0 | 4.12 % | $ 1.15 B | ||
|
Baxter International
BAX
|
-5.03 | $ 18.77 | 2.37 % | $ 9.63 B | ||
|
ResMed
RMD
|
22.7 | $ 209.86 | 0.98 % | $ 30.7 B | ||
|
AtriCure
ATRC
|
-1.92 | $ 29.0 | 0.69 % | $ 1.38 B | ||
|
Harvard Bioscience
HBIO
|
-353.72 | $ 5.4 | 7.78 % | $ 240 M | ||
|
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
-21.84 | $ 11.81 | 3.23 % | $ 482 M | ||
|
Becton, Dickinson and Company
BDX
|
10.16 | $ 146.95 | 0.02 % | $ 42.3 B | ||
|
Nephros
NEPH
|
11.23 | $ 3.57 | -1.79 % | $ 37.9 M | ||
|
OraSure Technologies
OSUR
|
-19.81 | $ 3.07 | -0.32 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
1.96 | $ 111.74 | 2.97 % | $ 6.28 M |